Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07017257 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Transcutaneous Auricular Vagus Nerve Stimulation for Persistent Post-concussion Symptoms

Study acronym: taVNS-PPCS
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Persistent post-concussive symptoms (PPCS) affect a significant proportion of individuals following a concussion, leading to debilitating impacts on their quality of life and work capacity. Currently, effective treatments for PPCS are limited, despite their lasting and debilitating impact. Transcutaneous auricular vagus nerve stimulation (taVNS), a non-invasive neuromodulation technique, holds promise as a therapeutic option by leveraging the bottom-up modulation of brain activity via the auricular branch of the vagus nerve. This study aims to evaluate the neurophysiological and clinical effects of taVNS on brain activity and symptomatology in patients with PPCS through a randomized, controlled, double-blind trial.
Trial Details
NCT Number NCT07017257
Lead Sponsor University of Liege
Collaborators: University Hospital Sart Tilman, Liege
Conditions
(from sponsor)		 Persistent Post-concussive Symptoms
Enrollment 48 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov